Infobionic
Search
  • Platform
  • Our Story
    • Leadership Team
    • Board of Directors
    • Strategic Advisory Board
  • Audiences
    • For EPs, Cardiologists, and Physicians
    • For Nurses, Techs, and Office Managers
  • Blog
  • News & Events
    • Press Releases
    • In the News
    • Events
  • Contact
  • Privacy Policy

Media Coverage

Virtual Telemetry Creating a World of New Options for Higher-Acuity Cardiac Patients

January 1, 2023 | Stuart Long 0 Minute Read
Share Post
Logo Orlando Med News

Don’t miss a beat.
Receive updates from our blog.



    You Might Also Like:

    Carient Media Coverage

    Two Stories, One Small Device That Saved Their Lives.

    May 22, 2023 | Belinda Sharr

    0 Minute Read

    Insurance Forums Logo 2 Media Coverage

    Majority of Americans Would Buy Health Insurance from Non-insurance Companies

    February 9, 2023 | Stuart Long

    0 Minute Read

    About the Author

    Stuart Long, Chief Executive Officer Stuart Long LinkedIn

    With more than 20 years of experience in the medical device market, Stuart Long champions InfoBionic’s commitment to widespread market adoption of the MoMe ARC Platform. In addition, Stuart is the architect of InfoBionic’s tacit culture™, a key element of its high team engagement and continued success.

    infobionic logo

    321 Billerica Road
    OfficeLink #5
    Chelmsford, MA 01824

    • Platform
    • Our Story
    • Audiences
    • Blog
    • News & Events
    • Contact
    • Privacy Policy
    • Facebook
    • Twitter
    • LinkedIn

    978.674.8304 | info@infobionic.com

    Copyright © 2023 Infobionic, All Rights Reserved.

     

    InfoBionic's MoMe® System may be covered under one or more of the following United States Patents: 8,478,418; 8,620,418; 8,744,561; 8,774,932; 8,798,734; 9,081,884; 9,307,914; 9,307,922; 9,968,274; 10,796,552; 10,595,737; 10,376,172; 10,332,379; 10,327,657; 10,297,132; 10,282,963 and 16/409,951. This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including the America Invents Act and 35 U.S.C. § 287(a). Additional patents may be issued or pending in the US and elsewhere